Creative Medical Technology Holdings, Inc. Income (Loss) from Continuing Operations, Per Basic Share
Creative Medical Technology Holdings, Inc. (CELZ) reported Income (Loss) from Continuing Operations, Per Basic Share of $0.00 per share for the 3-month period ending 2011-06-30, per its 10-Q/A filed 2011-08-25.
Discontinued › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsPerBasicShare · last filed 2011-08-25
- Creative Medical Technology Holdings, Inc. income (loss) from continuing operations, per basic share for the quarter ending 2011-06-30 was $0.00.
- Creative Medical Technology Holdings, Inc. income (loss) from continuing operations, per basic share for the quarter ending 2010-06-30 was $0.00.
| Period end | Income (Loss) from Continuing Operations, Per Basic Share 3 month | Income (Loss) from Continuing Operations, Per Basic Share 6 month |
|---|---|---|
| 2011-06-30 | $0.00 10-Q/A · filed 2011-08-25 | $0.00 10-Q/A · filed 2011-08-25 |
| 2010-06-30 | $0.00 10-Q/A · filed 2011-08-25 | $0.00 10-Q/A · filed 2011-08-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |